Company Filing History:
1 out of 15 
1 out of 70 
Years Active: 2001-2002
Title: Ariana Garcia Ojalvo: Innovator in Biotechnology
Introduction
Ariana Garcia Ojalvo is a prominent inventor based in Habana, Cuba. She has made significant contributions to the field of biotechnology, particularly in the development of streptokinase mutants. Her work focuses on genetic engineering techniques that have the potential to improve thrombolytic therapy.
Latest Patents
Ariana holds two patents, with her latest invention related to streptokinase mutants. This invention involves a method for obtaining mutants derived from the skc-2 gene coding for streptokinase SKC-2 (Heberkinase®). The goal of her research is to create streptokinase mutants that maintain their capacity for plasminogen activator complex formation while exhibiting reduced antigenicity. These mutants could serve as preferred alternatives to native streptokinase for treating conditions such as myocardial infarction, pulmonary thromboembolism, and other thrombosis-related disorders.
Career Highlights
Throughout her career, Ariana has worked at the Centro de Ingeniería Genética y Biotecnología, where she has contributed to various projects in biotechnology. Her expertise in genetic engineering has positioned her as a key figure in her field.
Collaborations
Ariana has collaborated with notable colleagues, including Isis Del Carmen Torrens Madrazo and Jose De La Fuente Garcia. These partnerships have enhanced her research and contributed to her innovative work in biotechnology.
Conclusion
Ariana Garcia Ojalvo is a trailblazer in the field of biotechnology, with her inventions paving the way for advancements in thrombolytic therapy. Her dedication to research and innovation continues to impact the medical field positively.